EGFR抑制剂
英文名 | CO-1686 (AVL-301) | CAS号 | 1374640-70-6 |
试剂别名 |
CO 1686;CO-1686 (AVL-301);CO-1686;N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acrylamide;N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;Pyridostadin;Rociletinib;Rociletinib(CO-1686);(N-(3-(2-(4-(4-acetylpiperazin-1-yl)-2-methoxyphenylamino)-5-(trifluoromethyl)pyrimidin-4-ylamino)phenyl)acrylamide);AVL-301;CNX-419;N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)prop-2-enamide;S7284,CNX-419,AVL-301;Co 1686
|
分子式 | C27H28F3N7O3 |
产品编号 | APEA3320 | 分子量 | 555.55 |
MDL号 |
产品名称: | EGFR抑制剂 |
英文名称: | CO-1686 (AVL-301) |
英文别名: | CO 1686;CO-1686 (AVL-301);CO-1686;N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acrylamide;N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;Pyridostadin;Rociletinib;Rociletinib(CO-1686);(N-(3-(2-(4-(4-acetylpiperazin-1-yl)-2-methoxyphenylamino)-5-(trifluoromethyl)pyrimidin-4-ylamino)phenyl)acrylamide);AVL-301;CNX-419;N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)prop-2-enamide;S7284,CNX-419,AVL-301;Co 1686 |
中文别名: | 4,6-二氢噻吩并[3,4-B]噻吩-2-羧酸;4-[(1,3-二氢-1-羟基-2,1-苯并氧杂硼杂环戊烷-5-基)氧基]苯甲腈;CO1686粉末;CO1686固体状;CO1686中间体;N-[3-[[2-[[4-(4-乙酰基-1-哌嗪基)-2-甲氧基苯基]氨基]-5-(三氟甲基)-4-嘧啶基]氨基]苯基]-2-丙烯酰胺;Rociletinib (CO-1686, AVL-301) 抑制剂;科研实验CO1686;临床实验CO1686;罗乐替尼;医药级CO1686;CO1686 |
CAS No.: | 1374640-70-6 |
分子式: | C27H28F3N7O3 |
分子量: | 555.55 |
危险品级别: | |
HS符号: | |
危害声明: |